Sorted By:

Relevance


PhRMA Welcomes Five New Member Companies

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
http://www.phrma.org/press-release/phrma-welcomes-five-new-member-companies

New Hampshire's 2016 Exchange Plans

PhRMA  |  Fact Sheet

States can continue to protect patients in their state through the following actions: Enforcing non-discrimination requirements, which apply to benefit design and provider networks; Establishing stronger rules regarding exceptions and appeals processes, which help enrollees get the medicines and care their doctors recommend; and Enhancing the state's marketplace website or advocating for a Healthcare.gov page that allows for easier plan comparisons, including searchable formularies and estimates of total out-of-pocket costs.
http://www.phrma.org/fact-sheet/new-hampshire-s-2016-exchange-plans

New Jersey's 2016 Exchange Plans

PhRMA  |  Fact Sheet

States can continue to protect patients in their state through the following actions: Enforcing non-discrimination requirements, which apply to benefit design and provider networks; Establishing stronger rules regarding exceptions and appeals processes, which help enrollees get the medicines and care their doctors recommend; and Enhancing the state's marketplace website or advocating for a Healthcare.gov page that allows for easier plan comparisons, including searchable formularies and estimates of total out-of-pocket costs.
http://www.phrma.org/fact-sheet/new-jersey-s-2016-exchange-plans

New non-discrimination rule neglects to define discriminatory benefits

PhRMA  |  Blog Post

Med. 399, 401 (2015), available at http://www.nejm.org/doi/pdf/10.1056/NEJMp1411376.
http://catalyst.phrma.org/new-non-discrimination-rule-neglects-to-define-discriminatory-benefits

New nonprofit – I-ACT for Children – launches to promote innovative medicines development for young patients in need

PhRMA  |  Blog Post

America’s biopharmaceutical companies are committed to bringing new medicines to patients in need, including those that are often most vulnerable – children – and we are proud to support this new initiative.
http://catalyst.phrma.org/new-nonprofit-i-act-for-children-launched-to-promote-innovative-medicines-development-for-young-patients-in-need

Average Net Brand Price Growth Declined as a Result of Increased Rebates

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-5/average-net-brand-price-growth-declined-as-a-result-of-increased-rebates

New York

Access Better Coverage  |  From Our Network

Enforcing non-discrimination requirements, which apply to benefit design and provider networks;  Establishing stronger rules regarding exceptions and appeals processes, which help enrollees get the medicines and care their doctors recommend; and   Enhancing the state's marketplace website or advocating for a Healthcare.gov page that allows for easier plan comparisons, including searchable formularies and estimates of total out-of-pocket costs.
http://www.accessbettercoverage.org/states/new-york

PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check

PhRMA  |  Blog Post

Listen to the full interview here, and visit .com/?
http://catalyst.phrma.org/phrma-ceo-talks-white-house-meeting-innovation-jobs-with-politicos-pulse-check

Why Do More Black Women Die of Breast Cancer? A Study Aims To Find Out

From Hope To Cures  |  From Our Network

“If you can identify who’s likely to get it, you may be able to develop a targeted way to identify them and get them the care that they need,” Dr.
http://www.fromhopetocures.org/why-do-more-black-women-die-of-breast-cancer-a-study-aims-to-find-out

Alzheimer's Webinar - July 15, 2015 at 1:30 pm EDT

PhRMA  |  Video

  New Report: Alzheimer’s Research “Setbacks” Critical for Breakthroughs of TomorrowRead PhRMA's Press Release on the Summer 2015 report
http://www.phrma.org/video/alzheimer-s-webinar-july-15-2015-at-1-30-pm-edt

PhRMA CEO Statement Following Meeting With President Trump

PhRMA  |  Blog Post


http://catalyst.phrma.org/phrma-ceo-statement-following-meeting-with-president-trump

The Biopharmaceutical Industry Invests More R&D Dollars per Employee Than Any Other Industry

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-7/the-biopharmaceutical-industry-invests-more-randd-dollars-per-employee-than-any-other-industry

New report provides recommendations for securing and protecting IP

PhRMA  |  Blog Post

Without the security of a strong IP system, biopharmaceutical researchers may not have the ability to explore new areas of medical innovation and unearth the findings that will lead to the treatments of tomorrow.
http://catalyst.phrma.org/new-report-provides-recommendations-for-securing-and-protecting-ip

UK Cancer Patients Face Increasing Coverage Restrictions Due to Centralized Cost-Effectiveness Standard, New Report Shows

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $550 billion in the search for new treatments and cures, including an estimated $51.1 billion in 2013 alone.
http://www.phrma.org/press-release/uk-cancer-patients-face-increasing-coverage-restrictions-due-to-centralized-cost-effectiveness-standard-new-report-shows

Are new hep C treatments cost effective? Doctors say answer is “a resounding yes”

PhRMA  |  Blog Post

The answer is yes.
http://catalyst.phrma.org/are-new-hep-c-treatments-cost-effective-doctors-say-answer-is-a-resounding-yes

Medicare Monday: New research finds drugs not a key driver of Medicare Part B costs

PhRMA  |  Blog Post

Learn more at PhRMA.org/Cost and check back with us on Medicare Monday.
http://catalyst.phrma.org/medicare-monday-new-research-finds-drugs-not-a-key-driver-of-medicare-part-b-costs

New Spanish-language resources added to ABCs En Español

PhRMA  |  Blog Post

Learn more about how we can better engage and empower patients, and visit AccessBetterCoverage.org for other English-language resources.
http://catalyst.phrma.org/new-spanish-language-resources-added-to-abcs-en-español

New Ads from America’s Biopharmaceutical Companies Feature Patients and Unsung Heroes Behind Cutting-Edge Scientific Advances

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
http://www.phrma.org/press-release/new-ads-from-america-s-biopharmaceutical-companies-feature-patients-and-unsung-heroes-behind-cutting-edge-scientific-advances

New PhRMA Report: Medicines in development for patients with rare diseases demonstrate the promise of innovation

PhRMA  |  Blog Post


http://catalyst.phrma.org/new-phrma-report-medicines-in-development-for-patients-with-rare-diseases-demonstrate-the-promise-of-innovation

New research: Insurance plan structure can have discriminatory effect

PhRMA  |  Blog Post

The Administration’s interest in thoughtfully examining the current risk adjuster and how it could be improved is an important first step to move policies forward that benefit patients.
http://catalyst.phrma.org/new-research-insurance-plan-structure-can-have-discriminatory-effect

PhRMA Statement on the Passing of Sen. Ted Kennedy

PhRMA  |  Press Release

PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines.
http://www.phrma.org/press-release/phrma-statement-on-the-passing-of-sen-ted-kennedy

Innovative Oncology Medicines Have Led to Impressive Gains in Patient Survivorship

PhRMA  |  Press Release

“With more than 5,000 medicines in the biopharmaceutical pipeline, including more than 3,000 potential medicines for cancer patients, the future looks bright for continued progress.
http://www.phrma.org/press-release/innovative-oncology-medicines-have-led-to-impressive-gains-in-patient-survivorship

New Jersey

Access Better Coverage  |  From Our Network

Enforcing non-discrimination requirements, which apply to benefit design and provider networks;  Establishing stronger rules regarding exceptions and appeals processes, which help enrollees get the medicines and care their doctors recommend; and   Enhancing the state's marketplace website or advocating for a Healthcare.gov page that allows for easier plan comparisons, including searchable formularies and estimates of total out-of-pocket costs.
http://www.accessbettercoverage.org/states/new-jersey

New Study: Patient cost sharing rising as plans push more costs to patients through deductibles, coinsurance

PhRMA  |  Blog Post

   [1] Kaiser/HRET data, “Among Covered Workers with a General Annual Health Plan Deductible for Single Coverage, Average Deductible, by Plan Type, 2006-2015,” available at http://kff.org/health-costs/report/2015-employer-health-benefits-survey/view/exhibits/ [2] Kaiser/HRET data for 2007 and 2015.
http://catalyst.phrma.org/new-study-patient-cost-sharing-rising-as-plans-push-more-costs-to-patients-through-deductibles-coinsurance

Medicare Monday: What does Medicare Part B Cover?

PhRMA  |  Blog Post

Check back with Medicare Monday for more on Part B and other aspects of Medicare next week.
http://catalyst.phrma.org/medicare-monday-what-does-medicare-part-b-cover

You have reviewed the first 75 results out of 1864. Each page contains 25 results. You're on page 3.

prev 1 2 3 4 5 6 next